Tessera Therapeutics
Tessera Therapeutics is an early-stage life sciences company, founded and backed by Flagship Pioneering, pioneering Gene Writing — a new category of genetic medicine designed to write therapeutic messages into the genome to treat and potentially cure disease at its source. Its Gene Writing platform uses mobile genetic elements delivered via lipid nanoparticles to insert genes and exons, make small insertions and deletions, or change single or multiple DNA base pairs, with applications spanning sickle cell disease, in vivo CAR-T, HIV, and other monogenic, metabolic, autoimmune, and neurodegenerative diseases. This API Evangelist profile tracks the company as a health-tech portfolio lead; Tessera is a therapeutics developer and does not currently publish a public developer or API surface.
Tessera Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Health Tech, Biotechnology, Gene Writing, and Genetic Medicine.
Tessera Therapeutics’ developer surface includes engineering blog, support, and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 3
The organization behind the API